Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Modulation of Micrornas Expression and Cellular Signaling Pathways Through Curcumin As a Potential Therapeutical Approach Against Ovarian Cancer: A Review Publisher Pubmed



Moazzami B1 ; Chaichian S2 ; Nikfar B1 ; Arbabi Bidgoli S3
Authors

Source: Pathology Research and Practice Published:2023


Abstract

Short non-coding RNAs called microRNAs (miRNAs) control gene expression by either inhibiting translation or degrading messenger RNA. MiRNAs are crucial for many biological functions, and the deregulation of their expression is strongly linked to the emergence of cancer. A single miRNA controls several gene expressions, allowing it to simultaneously control a number of cellular signaling pathways. As a result, miRNAs may be used as therapeutic targets as well as biomarkers for the prognosis and diagnosis of different cancers. Recent research has shown that natural compounds like curcumin, resveratrol and quercetin exert their pro-apoptotic and/or anti-proliferative impacts by modulating one and/or more miRNAs, which inhibits the growth of cancer cells, induces apoptosis, or increases the effectiveness of conventional cancer therapies. Here, we summarize the most recent developments in curcumin's control over the expression of miRNAs and emphasize the significance of these herbal remedies as a viable strategy in the treatment and prevention of cancer. © 2023 Elsevier GmbH
Other Related Docs
6. Microrna: A Novel Target of Curcumin in Cancer Therapy, Journal of Cellular Physiology (2018)
9. Curcumin: A New Candidate for Melanoma Therapy?, International Journal of Cancer (2016)
15. Targeting Mirna by Natural Products: A Novel Therapeutic Approach for Nonalcoholic Fatty Liver, Evidence-based Complementary and Alternative Medicine (2021)
19. Curcumin and Melanoma: From Chemistry to Medicine, Nutrition and Cancer (2018)
20. Natural Products in the Clinical Management of Metabolic Syndrome, Handbook of Experimental Pharmacology (2025)